Treeline Biosciences
5 known investors
Treeline Biosciences is a drug discovery and development company focused on designing therapeutics for cancer patients. It combines laboratory research and clinical insight to guide its oncology-focused drug design.
Founders & leadership
J
JeffCo-founder
JB
Josh BilenkerinFounder
Investors · 5
GV (Google Ventures)Mountain View · $250K – $50M
ARCH Venture PartnersreportedChicago · $50K – $250M
OrbiMedreportedNew York · $1M – $75M
Also in the syndicate · 2
AI Life SciencesKKR
Funding
SEC filings, press & company announcements$200M disclosed across 1 of 4 rounds · 2021–2025
- $200Mseries A extensionSep 2025 · 2 sources
ARCH Venture Partners (lead), GV (lead), OrbiMed (lead), AI Life Sciences, KKR
Source ↗ - Undisclosed amountSeries AApr 2021Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Treeline Biosciences do?
- Treeline Biosciences is a drug discovery and development company focused on designing therapeutics for cancer patients. It combines laboratory research and clinical insight to guide its oncology-focused drug design.
- Who founded Treeline Biosciences?
- Treeline Biosciences was founded by Jeff, Josh Bilenker.
- Who are Treeline Biosciences's investors?
- Treeline Biosciences's investors include GV (Google Ventures), ARCH Venture Partners, OrbiMed.
- How much funding has Treeline Biosciences raised?
- Treeline Biosciences has disclosed $200M raised across 1 of its 4 known rounds.